Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | ANPEP | P15144 | 2/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.44 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1901280 | 1.00 | ALDH1A1 (0.55) | ALDH1A1ANPEPRNPEPDNPEPSLC7A5 | |
| SCHEMBL7100850 | 0.81 | SLC7A5 (0.61) | ALDH1A1ANPEPRNPEPDNPEPSLC7A5 | |
| SCHEMBL530834 | 0.81 | SLC7A5 (0.61) | ALDH1A1ANPEPRNPEPDNPEPSLC7A5 | |
| Levacetylleucine SCHEMBL18283362 | 0.77 | ALDH1A1 (0.79) | ALDH1A1SLC7A5LTA4HLAP3MEN1 | |
| Acetylleucine SCHEMBL20898469 | 0.77 | ALDH1A1 (0.79) | ALDH1A1SLC7A5LTA4HLAP3MEN1 | |
| SCHEMBL14771687 | 0.74 | ALDH1A1 (0.62) | ALDH1A1LTA4HLAP3MEN1LMNA | |
| SCHEMBL15810880 | 0.74 | ALDH1A1 (0.67) | ALDH1A1LAP3MEN1LMNAKMT2A | |
| SCHEMBL7669779 | 0.74 | ALDH1A1 (0.67) | ALDH1A1LAP3MEN1LMNAKMT2A | |
| SCHEMBL7669784 | 0.74 | ALDH1A1 (0.67) | ALDH1A1LAP3MEN1LMNAKMT2A | |
| SCHEMBL13822102 | 0.73 | ALDH1A1 (0.72) | ALDH1A1LAP3MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9889102-B2 | Sigma receptor ligands and methods of modulating cellular protein homeostasis using same | DREXEL UNIVERSITY (US) | 2018-02-13 | — | — | US | claimed |
| US-20160361279-A1 | NOVEL SIGMA RECEPTOR LIGANDS AND METHODS OF MODULATING CELLULAR PROTEIN HOMEOSTASIS USING SAME | Philadelphia Health And Education Corporation, d/b/a Drexel University College of Medicine | 2016-12-15 | — | — | US | claimed |
| EP-1030917-A1 | TRANSCRIPTIONALLY REGULATED G PROTEIN-COUPLED RECEPTOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-08-30 | — | — | EP | claimed |
| WO-1999025830-A1 | TRANSCRIPTIONALLY REGULATED G PROTEIN-COUPLED RECEPTOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-05-27 | — | — | WO | claimed |
| US-12398108-B2 | Compounds, compositions, and methods for treating diseases | DREXEL UNIVERSITY (US) | 2025-08-26 | — | — | US | disclosed |
| US-20240366741-A1 | NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2024-11-07 | — | — | US | disclosed |
| US-20230416206-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES | UNIV DREXEL (US) | 2023-12-28 | — | — | US | disclosed |
| WO-2022192163-A1 | NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2022-09-15 | — | — | WO | disclosed |
| US-20220001014-A1 | COMPOSITIONS AND METHODS FOR INDUCING BIOLOGICAL MIMICRY IN A MAMMAL FOR THE PREVENTION AND/OR TREATMENT OF COVID-19 AND OTHER DISEASES | GHADERI LIDA (US) | 2022-01-06 | — | — | US | disclosed |
| US-20210403436-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES | UNIV DREXEL (US) | 2021-12-30 | — | — | US | disclosed |
| US-11117870-B2 | Compounds, compositions, and methods for treating diseases | DREXEL UNIVERSITY (US) | 2021-09-14 | — | — | US | disclosed |
| US-20200339519-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES | DREXEL UNIVERSITY (US) | 2020-10-29 | — | — | US | disclosed |
| EP-2819665-A1 | PROTEASE INHIBITORS FOR TREATING TRICHOMONAS GALLINAE INFECTIONS | Veterinärmedizinische Universität Wien (AT) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013127981-A1 | PROTEASE INHIBITORS FOR TREATING TRICHOMONAS GALLINAE INFECTIONS | VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2013-09-06 | — | — | WO | disclosed |
| US-6514696-B1 | Detection thereof; Using polynucleotide that hybridizes to given nucleotide sequence; Cancer | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-02-04 | — | — | US | disclosed |
| US-6383760-B1 | CONTACTING RECEPTOR WITH TEST COMPOUND, THEN DETERMINING IF COMPOUND BINDS TO RECEPTOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-05-07 | — | — | US | disclosed |
| WO-2001081918-A1 | TRANSCRIPTIONALLY REGULATED G PROTEIN-COUPLED RECEPTOR G2A | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-11-01 | — | — | WO | disclosed |
| US-6214562-B1 | DETECTING LIGANDS WHICH PREFERENTIALY BIND CONTROLLING PROTEINS; INCUBATE BINDING PROTEIN WITH LIGAND AND DETECT BINDING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-04-10 | — | — | US | disclosed |
| EP-1030917-A1 | TRANSCRIPTIONALLY REGULATED G PROTEIN-COUPLED RECEPTOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-08-30 | — | — | EP | disclosed |
| WO-1999025830-A1 | TRANSCRIPTIONALLY REGULATED G PROTEIN-COUPLED RECEPTOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339519-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES | SIGMAR1, OPRK1, OPRM1 | ALDH1A1 464/4885ANPEP 3428/4885RNPEP 2191/4885 |
| US-11117870-B2 | Compounds, compositions, and methods for treating diseases | SIGMAR1, OPRK1, OPRM1 | ALDH1A1 464/4885ANPEP 3428/4885RNPEP 2191/4885 |
| US-12398108-B2 | Compounds, compositions, and methods for treating diseases | SIGMAR1, OPRK1, OPRM1 | ALDH1A1 252/4885ANPEP 3760/4885RNPEP 2622/4885 |
| US-20210403436-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES | SIGMAR1, OPRL1, NR1H3 | ALDH1A1 678/4885ANPEP 3459/4885RNPEP 2289/4885 |
| US-20160361279-A1 | NOVEL SIGMA RECEPTOR LIGANDS AND METHODS OF MODULATING CELLULAR PROTEIN HOMEOSTASIS USING SAME | TMEM97, SIGMAR1, ADRM1 | ALDH1A1 3691/4885ANPEP 3680/4885RNPEP 3508/4885 |
| US-20230416206-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES | SIGMAR1, OPRK1, OPRM1 | ALDH1A1 252/4885ANPEP 3760/4885RNPEP 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.